Nutritional status and nutritional risk in patients with neuroendocrine tumors

References

• Bozzetti F, Mariani L, Lo Vullo S, et al. The nutritional risk in oncology: a study of 1,453 cancer outpatients. Support Care Cancer. 2012;20:1919–1928.
   PubMed Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–495.
   PubMed Web of Science ®Google Scholar
• Martin L, Senesse P, Gioulbasanis I, et al. Diagnostic criteria for the classification of cancer-associated weight loss. JCO. 2015;33:90–99.
   PubMed Web of Science ®Google Scholar
• Isenring E, Cross G, Kellett E, et al. Nutritional status and information needs of medical oncology patients receiving treatment at an Australian public hospital. Nutr Cancer. 2010;62:220–228.
   PubMed Web of Science ®Google Scholar
• Caccialanza R, Pedrazzoli P, Cereda E, et al. Nutritional support in cancer patients: a position paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE). J Cancer. 2016;7:131–135.
   PubMed Web of Science ®Google Scholar
• Pan H, Cai S, Ji J, et al. The impact of nutritional status, nutritional risk, and nutritional treatment on clinical outcome of 2248 hospitalized cancer patients: a multi-center, prospective cohort study in Chinese teaching hospitals. Nutr Cancer. 2013;65:62–70.
   PubMed Web of Science ®Google Scholar
• Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22:415–421.
   PubMed Web of Science ®Google Scholar
• Kubrak C, Olson K, Baracos VE. The Head and Neck Symptom Checklist©: an instrument to evaluate nutrition impact symptoms effect on energy intake and weight loss. Support Care Cancer. 2013;21:3127–3136.
   PubMed Web of Science ®Google Scholar
• Omlin A, Blum D, Wierecky J, et al. Nutrition impact symptoms in advanced cancer: frequency and specific interventions, a case-control study. J Cachexia Sarcopenia Muscle. 2013;4:55–61.
   PubMed Web of Science ®Google Scholar
• Orell-Kotikangas H, Österlund P, Saarilahti K, et al. NRRS-2002 for pretreament at nutritional risk screening and nutritional status assessment in head and neck cancer patients. Support Care Cancer. 2015;23:1495–1502.
   PubMed Web of Science ®Google Scholar
• Arends J, Bachmann P, Baracos V, et al. Espen guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–38.
   PubMed Web of Science ®Google Scholar
• Andreyev HJ, Norman AR, Oates J, et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998;34:503–509.
   PubMed Web of Science ®Google Scholar
• Pressoir M, Desne S, Berchery D, et al. Prevalence, risk factors and clinical implications of malnutrition in French comprehensive cancer centres. Br J Cancer. 2010;102:966–971.
   PubMed Web of Science ®Google Scholar
• Maasberg S, Knappe-Drzikova B, Vonderbeck D, et al. Malnutrition predicts clinical outcome in patients with neuroendocrine Neoplasia. Neuroendocrinology. 2017;104:11–25.
   PubMed Web of Science ®Google Scholar
• Qureshi S, Burch N, Druce M, et al. Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study. BMJ Open. 2016;6:e010765. doi:10.1136/bmjopen-2015
   PubMed Web of Science ®Google Scholar
• Ter-Minassian M, Chan JA, Hooshmand SM, et al. Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database. Endocr Relat Cancer. 2013;20:187–196.
   PubMed Web of Science ®Google Scholar
• Fiebrich HB, van den Berg G, Kema IP, et al. Deficiencies in fat-soluble vitamins in long-term users of somatostatin analogue. Aliment Pharmacol Therapeut. 2010;32:1398–1404.
   PubMed Web of Science ®Google Scholar
• Ekeblad S, Skogseid B, Dunder K, et al. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res. 2008;14:7798–7803.
   PubMed Web of Science ®Google Scholar
• Yao JC, Hassan M, Phan A, et al. One hundred years after ‘carcinoid’: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–3072.
   PubMed Web of Science ®Google Scholar
• Vinik AI, Woltering EA, Warner RR, Caplin M, et al. NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas. 2010;39:713–734.
   PubMed Web of Science ®Google Scholar
• Vinik AL. Advances in diagnosis and treatment of pancreatic neuroendocrine tumors. Endocr Pract. 2014;20:1222–1230.
   PubMed Web of Science ®Google Scholar
• Pavel M, Baudin E, Couvelard A, et al. ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut and unknown primary. ENETS consensus guidelines. Neuroendocrinology. 2012;95:157–176.
   PubMed Web of Science ®Google Scholar
• Marrache F, Vullierme MP, Roy C, et al. Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours. Br J Cancer. 2007;96:49–55.
   PubMed Web of Science ®Google Scholar
• Norman K, Stobäus N, Smoliner C, et al. Determinants of hand grip strength, knee extension strength and functional status in cancer patients. Clin Nutr. 2010;29:586–591.
   PubMed Web of Science ®Google Scholar
• Norman K, Stobäus N, Gonzalez C, et al. Hand grip strength: outcome predictor and marker of nutritional status. Clin Nutr. 2011;30:135–142.
   PubMed Web of Science ®Google Scholar
• Flood A, Chung A, Parker H, et al. The use of hand grip strength as a predictor of nutrition status in hospital patients. Clin Nutr. 2014;33:106–114.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bayens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European working group on Sarcopenia in older people. Age Ageing. 2010;39:412–423.
   PubMed Web of Science ®Google Scholar
• Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurements of grip strength in clinical and epidemiological studies: towards a standardized approach. Age Ageing. 2011;40:423–429.
   PubMed Web of Science ®Google Scholar
• Álvares-da-Silva M, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005;21:113–117.
   PubMed Web of Science ®Google Scholar
• Bohannon RW, Peolsson A, Massy-Westropp N, et al. Reference values for adult grip strength measured with a Jamar dynamometer: a descriptive meta-analysis. Physiotherapy. 2006;92:11–15.
   Web of Science ®Google Scholar
• Nordén J, Gronberg AM, Bosaeus I, et al. Nutrition impact symptoms and body composition in patients with COPD. Eur J Clin Nutr. 2015;69:256–261.
   PubMed Web of Science ®Google Scholar
• Knudsen Wilkens A, Naver A, Bisgaard K, et al. Nutrition impact symptoms, handgrip strength and nutritional risk in hospitalized patients with gastroenterological and liver diseases. Scand J Gastroenterol. 2015;50:1191–1198.
   PubMed Web of Science ®Google Scholar
• Abbott J, Teleni L, McKavanagh D, et al. Patient-generated subjective global assessment short form (PG-SGS SF) is a valid screening tool in chemotherapy outpatients. Support Care Cancer. 2016;24:3883–3887.
   PubMed Web of Science ®Google Scholar
• Del Fabbro E, Hui D, Dalal S, et al. Clinical outcomes and contributors to weight loss in a cancer cachexia clinic. J Palliat Med. 2011;14:1004–1008.
   PubMed Web of Science ®Google Scholar
• Kyle U, Kossovsky M, Karsegard V, et al. Comparison of tools for nutritional assessment and screening at hospital admission: a population study. Clinical Nutrition. 2006;25:409–417.
   PubMed Web of Science ®Google Scholar
• Bole O, Tome C, Monteiro-Grillo I, Camilo ME, et al. Validation of the malnutrition universal screening tool (MUST) in cancer. Br J Nutr. 2012;108:343–348.
   PubMed Web of Science ®Google Scholar
• Caplin M, Pavel M, Jarosław B, Ćwikła JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371:224–233.
   PubMed Web of Science ®Google Scholar
• Ravasco P, Monteiro-Grillo I, Vidal PM, et al. Cancer: disease and nutrition are key determinants of patients quality of life. Support Care Cancer. 2004;12:246–252.
   PubMed Web of Science ®Google Scholar
• Ravasco P, Monteiro-Grillo I, Vidal PM, et al. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol. 2005;23:1431–1438.
   PubMed Web of Science ®Google Scholar
• Matos LC, Tavares MM, Amaral TF. Hand Grip Strength as a hospital admission nutritional risk screening method. Eur J Clin Nutr. 2007;61:1128–1135.
   PubMed Web of Science ®Google Scholar